Exact Mass: 574.3509

CucurbitacinA

C32H46O9 (574.3142)

Cucurbitacin A is a cucurbitacin. Cucurbitacin A is a natural product found in Hintonia standleyana, Cucumis prophetarum, and other organisms with data available.

Ganoderic acid K

C32H46O9 (574.3142)

Ganoderic acid K is found in mushrooms. Ganoderic acid K is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid K is found in mushrooms.

Ganoderic acid alpha

C32H46O9 (574.3142)

Ganoderic acid alpha is found in mushrooms. Ganoderic acid alpha is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). Ganoderic acid alpha is found in mushrooms.

3-Benzoyloxy-6-oxo-12-ursen-28-oic acid

C37H50O5 (574.3658)

3-Benzoyloxy-6-oxo-12-ursen-28-oic acid is found in fruits. 3-Benzoyloxy-6-oxo-12-ursen-28-oic acid is a constituent of the famine food Momordica dioica. Constituent of the famine food Momordica dioica. 3-Benzoyloxy-6-oxo-12-ursen-28-oic acid is found in fruits.

3-Benzoyloxy-11-oxo-12-ursen-28-oic acid

C37H50O5 (574.3658)

3-Benzoyloxy-11-oxo-12-ursen-28-oic acid is found in fruits. 3-Benzoyloxy-11-oxo-12-ursen-28-oic acid is a constituent of the famine food Momordica dioica. Constituent of the famine food Momordica dioica. 3-Benzoyloxy-11-oxo-12-ursen-28-oic acid is found in fruits.

(2R)-2-[[(1R,3S,4S)-3-[[4-(5-Benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-(3-fluorophenyl)cyclopentyl]-methylamino]-3-methylbutanoic acid

C35H47FN4O2 (574.3683)

Phorbol myristate

C34H54O7 (574.3869)

Phorbol-12-monomyristate

C34H54O7 (574.3869)

PA(8:0/18:2(10E,12Z)+=O(9))

C29H51O9P (574.3271)

PA(8:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(10E,12Z)+=O(9)/8:0)

C29H51O9P (574.3271)

PA(18:2(10E,12Z)+=O(9)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/8:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:2(9Z,11E)+=O(13))

C29H51O9P (574.3271)

PA(8:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(9Z,11E)+=O(13)/8:0)

C29H51O9P (574.3271)

PA(18:2(9Z,11E)+=O(13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/8:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:3(10,12,15)-OH(9))

C29H51O9P (574.3271)

PA(8:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(10,12,15)-OH(9)/8:0)

C29H51O9P (574.3271)

PA(18:3(10,12,15)-OH(9)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/8:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/18:3(9,11,15)-OH(13))

C29H51O9P (574.3271)

PA(8:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(9,11,15)-OH(13)/8:0)

C29H51O9P (574.3271)

PA(18:3(9,11,15)-OH(13)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/8:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Cucurbitacin A

C32H46O9 (574.3142)

Cucurbitacin a is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin a is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin a can be found in cucumber, which makes cucurbitacin a a potential biomarker for the consumption of this food product.

solasodine 3-O-beta-D-glucopyranoside

C33H52NO7 (574.3744)

Solasodine 3-o-beta-d-glucopyranoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Solasodine 3-o-beta-d-glucopyranoside can be found in a number of food items such as black crowberry, canada blueberry, fig, and cherry tomato, which makes solasodine 3-o-beta-d-glucopyranoside a potential biomarker for the consumption of these food products.

Galphimine G

C32H46O9 (574.3142)

Galphimine D

C32H46O9 (574.3142)

Rubianol e

C34H54O7 (574.3869)

2-O-Acetylcerleaside A

C32H46O9 (574.3142)

Cephalosporin P1

C33H50O8 (574.3506)

Leucopaxillone A

C34H54O7 (574.3869)

Galphimine I

C32H46O9 (574.3142)

Galphimine E

C32H46O9 (574.3142)

13beta,29-Dihydroxymilbemycin A4

C32H46O9 (574.3142)

Irumanolide I

C34H54O7 (574.3869)

Oxohygrolidin

C34H54O7 (574.3869)

Cucurbitacin

C33H50O8 (574.3506)

Spirostan-2,3,27-triol, triacetate, (2.alpha.,3.beta.,5.alpha.,25S)-

C33H50O8 (574.3506)

Piscidinol D

C32H46O9 (574.3142)

Isocephalosporin P(1)

C33H50O8 (574.3506)

5beta,6beta-epoxygorgostane-1alpha,3beta,11alpha,15alpha-tetrol 11,15-diacetate

C34H54O7 (574.3869)

Anhydrodebromoaplysiatoxin

C32H46O9 (574.3142)

3-epi-Sceptrumgenin-3-beta-D-glucopyranosid

C33H50O8 (574.3506)

1-benzoyl-2-methoxy-8,8-dimethyl-4,5-bis(3-methylbut-2-enyl)-7-[(3-methyl-4-acetoxy-but-2-enyl)]endo-bicyclo[3.3.1]non-2-ene-4,9-dione

C36H46O6 (574.3294)

Thesine

C34H42N2O6 (574.3043)

Brasiliensophyllic acid C

C36H46O6 (574.3294)

Sanguisorbin B

C34H54O7 (574.3869)

3beta-O-(2-O-acetyl-alpha-L-thevetosyl)-14beta-hydroxy-7-en-5beta-card-20(22)-enolide|3??-O-(2-O-Acetyl-??-L-thevetosyl)-14??-hydroxy-7-en-5??-card-20(22)-enolide|7,8-dehydrocerberin

C32H46O9 (574.3142)

Phytolaccagenin A

C33H50O8 (574.3506)

Napoleogenol

C34H54O7 (574.3869)

15alpha-hydroxy-16-dehydroxy-16(24)-en-foetidinol-3-O-beta-D-xylopyranoside

C32H46O9 (574.3142)

C34H42N2O6

C34H42N2O6 (574.3043)

microginin 91-A

C28H51ClN4O6 (574.3497)

C34H54O7

C34H54O7 (574.3869)

gorgost-5-ene-3beta,7alpha,11alpha,12beta,15alpha-pentol 11,15-diacetate

C34H54O7 (574.3869)

NSC281269

C34H54O7 (574.3869)

(22R,24xi)-24-methylcholest-5-en-3beta,22,25,28-tetraol-3,22,28-triacetate

C34H54O7 (574.3869)

7beta-hydroxycucurbitacin B

C32H46O9 (574.3142)

brujavanone D

C33H50O8 (574.3506)

butyl lucidenate P

C33H50O8 (574.3506)

Teraspiridole B_130089

C34H42N2O6 (574.3043)

leucoridine D

C38H46N4O (574.3671)

12-O-decanoyl-7-oxo-5-ene-phorbol-13-acetate|12-O-neodecanoyl-7-oxo-5-enephorbol-13-acetate|daphwanin

C32H46O9 (574.3142)

pouogenin C

C34H54O7 (574.3869)

A natural product found in Lipastrotethya species.

SCHEMBL13641596

C38H46N4O (574.3671)

12alpha-acetoxy-16beta-(3-hydroxypentanoyloxy)-20,24-dimethyl-24-oxoscalaran-25-al

C34H54O7 (574.3869)

C32H46O9

C32H46O9 (574.3142)

3beta-O-(2-O-acetyl-alpha-L-acofriosyl)-16-anhydrogitoxigenin|vallarisoside

C32H46O9 (574.3142)

milbemycin beta10

C33H50O8 (574.3506)

chisiamol C

C34H54O7 (574.3869)

Turbicoryn

C29H50O11 (574.3353)

3alpha,22alpha-diacetoxy-21alpha,29-dihydroxy-20beta-methoxy-30-norolean-12-ene

C34H54O7 (574.3869)

3-hydroxy-3,5-dimethylheptanoic acid rel-(1R,4R,4aR,7aR,8aR,10S,11S,11aR,12aR,13aR)-1,2,4,4a,5,7a,8,8a,9,10,11,11a,12,12a,13,13a-hexadecahydro-1,13a-dihydroxy-4,7-dimethyl-13-methylene-11-(1-methylethyl)-2-oxoindeno[5,6:4,5]cycloocta[1,2-c]pyran-10...

C34H54O7 (574.3869)

inocalophyllin A methyl ester

C36H46O6 (574.3294)

gorgost-5-ene-3beta,7alpha,11alpha,12beta,15alpha-pentol 12,15-diacetate

C34H54O7 (574.3869)

Ile Ile Arg Ser Ser

C24H46N8O8 (574.3438)

Met Leu Arg Ala Ala

C24H46N8O6S (574.3261)

Val Leu Lys Asp Ser

C25H46N6O9 (574.3326)

Lys Leu Glu Ala Thr

C25H46N6O9 (574.3326)

Lys Asn Asn Thr Val

C23H42N8O9 (574.3075)

Glu Arg Ile Ala Ser

C23H42N8O9 (574.3075)

Ganoderic acid alpha

C32H46O9 (574.3142)

Ganoderic Acid K

C32H46O9 (574.3142)

Cyclosieversigenin Derivative: 3,6-Di-Ac

C34H54O7 (574.3869)

SubCategory_DNP: : Triterpenoids

MK-578

C35H47FN4O2 (574.3683)

CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3568; ORIGINAL_PRECURSOR_SCAN_NO 3566 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3544; ORIGINAL_PRECURSOR_SCAN_NO 3541 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3586; ORIGINAL_PRECURSOR_SCAN_NO 3584 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3537; ORIGINAL_PRECURSOR_SCAN_NO 3535 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3552; ORIGINAL_PRECURSOR_SCAN_NO 3550 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3592; ORIGINAL_PRECURSOR_SCAN_NO 3591 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7584; ORIGINAL_PRECURSOR_SCAN_NO 7580 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7597; ORIGINAL_PRECURSOR_SCAN_NO 7596 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7619; ORIGINAL_PRECURSOR_SCAN_NO 7617 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7604; ORIGINAL_PRECURSOR_SCAN_NO 7602 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7625; ORIGINAL_PRECURSOR_SCAN_NO 7623 CONFIDENCE standard compound; INTERNAL_ID 1218; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7627; ORIGINAL_PRECURSOR_SCAN_NO 7623

Glu Ile Lys Trp

C28H42N6O7 (574.3115)

Glu Ile Trp Lys

C28H42N6O7 (574.3115)

Glu Lys Ile Trp

C28H42N6O7 (574.3115)

Glu Lys Leu Trp

C28H42N6O7 (574.3115)

Glu Lys Trp Ile

C28H42N6O7 (574.3115)

Glu Lys Trp Leu

C28H42N6O7 (574.3115)

Glu Leu Lys Trp

C28H42N6O7 (574.3115)

Glu Leu Trp Lys

C28H42N6O7 (574.3115)

Glu Trp Ile Lys

C28H42N6O7 (574.3115)

Glu Trp Lys Ile

C28H42N6O7 (574.3115)

Glu Trp Lys Leu

C28H42N6O7 (574.3115)

Glu Trp Leu Lys

C28H42N6O7 (574.3115)

Phe Pro Arg Arg

C26H42N10O5 (574.3339)

Phe Arg Pro Arg

C26H42N10O5 (574.3339)

Phe Arg Arg Pro

C26H42N10O5 (574.3339)

His Lys Lys Tyr

C27H42N8O6 (574.3227)

His Lys Tyr Lys

C27H42N8O6 (574.3227)

His Tyr Lys Lys

C27H42N8O6 (574.3227)

Ile Glu Lys Trp

C28H42N6O7 (574.3115)

Ile Glu Trp Lys

C28H42N6O7 (574.3115)

Ile Lys Glu Trp

C28H42N6O7 (574.3115)

Ile Lys Trp Glu

C28H42N6O7 (574.3115)

Ile Met Arg Arg

C23H46N10O5S (574.3373)

Ile Arg Met Arg

C23H46N10O5S (574.3373)

Ile Arg Arg Met

C23H46N10O5S (574.3373)

Ile Arg Thr Trp

C27H42N8O6 (574.3227)

Ile Arg Trp Thr

C27H42N8O6 (574.3227)

Ile Thr Arg Trp

C27H42N8O6 (574.3227)

Ile Thr Trp Arg

C27H42N8O6 (574.3227)

Ile Trp Glu Lys

C28H42N6O7 (574.3115)

Ile Trp Lys Glu

C28H42N6O7 (574.3115)

Ile Trp Arg Thr

C27H42N8O6 (574.3227)

Ile Trp Thr Arg

C27H42N8O6 (574.3227)

Lys Glu Ile Trp

C28H42N6O7 (574.3115)

Lys Glu Leu Trp

C28H42N6O7 (574.3115)

Lys Glu Trp Ile

C28H42N6O7 (574.3115)

Lys Glu Trp Leu

C28H42N6O7 (574.3115)

Lys His Lys Tyr

C27H42N8O6 (574.3227)

Lys His Tyr Lys

C27H42N8O6 (574.3227)

Lys Ile Glu Trp

C28H42N6O7 (574.3115)

Lys Ile Trp Glu

C28H42N6O7 (574.3115)

Lys Lys His Tyr

C27H42N8O6 (574.3227)

Lys Lys Asn Trp

C27H42N8O6 (574.3227)

Lys Lys Trp Asn

C27H42N8O6 (574.3227)

Lys Lys Tyr His

C27H42N8O6 (574.3227)

Lys Leu Glu Trp

C28H42N6O7 (574.3115)

Lys Leu Trp Glu

C28H42N6O7 (574.3115)

Lys Asn Lys Trp

C27H42N8O6 (574.3227)

Lys Asn Trp Lys

C27H42N8O6 (574.3227)

Lys Trp Glu Ile

C28H42N6O7 (574.3115)

Lys Trp Glu Leu

C28H42N6O7 (574.3115)

Lys Trp Ile Glu

C28H42N6O7 (574.3115)

Lys Trp Lys Asn

C27H42N8O6 (574.3227)

Lys Trp Leu Glu

C28H42N6O7 (574.3115)

Lys Trp Asn Lys

C27H42N8O6 (574.3227)

Lys Tyr His Lys

C27H42N8O6 (574.3227)

Lys Tyr Lys His

C27H42N8O6 (574.3227)

Leu Glu Lys Trp

C28H42N6O7 (574.3115)

Leu Glu Trp Lys

C28H42N6O7 (574.3115)

Leu Lys Glu Trp

C28H42N6O7 (574.3115)

Leu Lys Trp Glu

C28H42N6O7 (574.3115)

Leu Met Arg Arg

C23H46N10O5S (574.3373)

Leu Arg Met Arg

C23H46N10O5S (574.3373)

Leu Arg Arg Met

C23H46N10O5S (574.3373)

Leu Arg Thr Trp

C27H42N8O6 (574.3227)

Leu Arg Trp Thr

C27H42N8O6 (574.3227)

Leu Thr Arg Trp

C27H42N8O6 (574.3227)

Leu Thr Trp Arg

C27H42N8O6 (574.3227)

Leu Trp Glu Lys

C28H42N6O7 (574.3115)

Leu Trp Lys Glu

C28H42N6O7 (574.3115)

Leu Trp Arg Thr

C27H42N8O6 (574.3227)

Leu Trp Thr Arg

C27H42N8O6 (574.3227)

Met Ile Arg Arg

C23H46N10O5S (574.3373)

Met Leu Arg Arg

C23H46N10O5S (574.3373)

Met Arg Ile Arg

C23H46N10O5S (574.3373)

Met Arg Leu Arg

C23H46N10O5S (574.3373)

Met Arg Arg Ile

C23H46N10O5S (574.3373)

Met Arg Arg Leu

C23H46N10O5S (574.3373)

Asn Lys Lys Trp

C27H42N8O6 (574.3227)

Asn Lys Trp Lys

C27H42N8O6 (574.3227)

Asn Trp Lys Lys

C27H42N8O6 (574.3227)

Pro Phe Arg Arg

C26H42N10O5 (574.3339)

Pro Arg Phe Arg

C26H42N10O5 (574.3339)

Pro Arg Arg Phe

C26H42N10O5 (574.3339)

Arg Phe Pro Arg

C26H42N10O5 (574.3339)

Arg Phe Arg Pro

C26H42N10O5 (574.3339)

Arg Ile Met Arg

C23H46N10O5S (574.3373)

Arg Ile Arg Met

C23H46N10O5S (574.3373)

Arg Ile Thr Trp

C27H42N8O6 (574.3227)

Arg Ile Trp Thr

C27H42N8O6 (574.3227)

Arg Leu Met Arg

C23H46N10O5S (574.3373)

Arg Leu Arg Met

C23H46N10O5S (574.3373)

Arg Leu Thr Trp

C27H42N8O6 (574.3227)

Arg Leu Trp Thr

C27H42N8O6 (574.3227)

Arg Met Ile Arg

C23H46N10O5S (574.3373)

Arg Met Leu Arg

C23H46N10O5S (574.3373)

Arg Met Arg Ile

C23H46N10O5S (574.3373)

Arg Met Arg Leu

C23H46N10O5S (574.3373)

Arg Pro Phe Arg

C26H42N10O5 (574.3339)

Arg Pro Arg Phe

C26H42N10O5 (574.3339)

Arg Arg Phe Pro

C26H42N10O5 (574.3339)

Arg Arg Ile Met

C23H46N10O5S (574.3373)

Arg Arg Leu Met

C23H46N10O5S (574.3373)

Arg Arg Met Ile

C23H46N10O5S (574.3373)

Arg Arg Met Leu

C23H46N10O5S (574.3373)

Arg Arg Pro Phe

C26H42N10O5 (574.3339)

Arg Thr Ile Trp

C27H42N8O6 (574.3227)

Arg Thr Leu Trp

C27H42N8O6 (574.3227)

Arg Thr Trp Ile

C27H42N8O6 (574.3227)

Arg Thr Trp Leu

C27H42N8O6 (574.3227)

Arg Trp Ile Thr

C27H42N8O6 (574.3227)

Arg Trp Leu Thr

C27H42N8O6 (574.3227)

Arg Trp Thr Ile

C27H42N8O6 (574.3227)

Arg Trp Thr Leu

C27H42N8O6 (574.3227)

Thr Ile Arg Trp

C27H42N8O6 (574.3227)

Thr Ile Trp Arg

C27H42N8O6 (574.3227)

Thr Leu Arg Trp

C27H42N8O6 (574.3227)

Thr Leu Trp Arg

C27H42N8O6 (574.3227)

Thr Arg Ile Trp

C27H42N8O6 (574.3227)

Thr Arg Leu Trp

C27H42N8O6 (574.3227)

Thr Arg Trp Ile

C27H42N8O6 (574.3227)

Thr Arg Trp Leu

C27H42N8O6 (574.3227)

Thr Trp Ile Arg

C27H42N8O6 (574.3227)

Thr Trp Leu Arg

C27H42N8O6 (574.3227)

Thr Trp Arg Ile

C27H42N8O6 (574.3227)

Thr Trp Arg Leu

C27H42N8O6 (574.3227)

Trp Glu Ile Lys

C28H42N6O7 (574.3115)

Trp Glu Lys Ile

C28H42N6O7 (574.3115)

Trp Glu Lys Leu

C28H42N6O7 (574.3115)

Trp Glu Leu Lys

C28H42N6O7 (574.3115)

Trp Ile Glu Lys

C28H42N6O7 (574.3115)

Trp Ile Lys Glu

C28H42N6O7 (574.3115)

Trp Ile Arg Thr

C27H42N8O6 (574.3227)

Trp Ile Thr Arg

C27H42N8O6 (574.3227)

Trp Lys Glu Ile

C28H42N6O7 (574.3115)

Trp Lys Glu Leu

C28H42N6O7 (574.3115)

Trp Lys Ile Glu

C28H42N6O7 (574.3115)

Trp Lys Lys Asn

C27H42N8O6 (574.3227)

Trp Lys Leu Glu

C28H42N6O7 (574.3115)

Trp Lys Asn Lys

C27H42N8O6 (574.3227)

Trp Leu Glu Lys

C28H42N6O7 (574.3115)

Trp Leu Lys Glu

C28H42N6O7 (574.3115)

Trp Leu Arg Thr

C27H42N8O6 (574.3227)

Trp Leu Thr Arg

C27H42N8O6 (574.3227)

Trp Asn Lys Lys

C27H42N8O6 (574.3227)

Trp Arg Ile Thr

C27H42N8O6 (574.3227)

Trp Arg Leu Thr

C27H42N8O6 (574.3227)

Trp Arg Thr Ile

C27H42N8O6 (574.3227)

Trp Arg Thr Leu

C27H42N8O6 (574.3227)

Trp Thr Ile Arg

C27H42N8O6 (574.3227)

Trp Thr Leu Arg

C27H42N8O6 (574.3227)

Trp Thr Arg Ile

C27H42N8O6 (574.3227)

Trp Thr Arg Leu

C27H42N8O6 (574.3227)

Tyr His Lys Lys

C27H42N8O6 (574.3227)

Tyr Lys His Lys

C27H42N8O6 (574.3227)

Tyr Lys Lys His

C27H42N8O6 (574.3227)

TEGLR

C23H42N8O9 (574.3075)

DALRT

C23H42N8O9 (574.3075)

LREGT

C23H42N8O9 (574.3075)

KTITL

C26H50N6O8 (574.369)

KDLSL

C25H46N6O9 (574.3326)

KNNTV

C23H42N8O9 (574.3075)

ERIAS

C23H42N8O9 (574.3075)

IIRSS

C24H46N8O8 (574.3438)

3-Benzoyloxy-6-oxo-12-ursen-28-oic acid

C37H50O5 (574.3658)

3-Benzoyloxy-11-oxo-12-ursen-28-oic acid

C37H50O5 (574.3658)

ST 32:6;O9

C32H46O9 (574.3142)

ST 34:4;O7

C34H54O7 (574.3869)

3-Methoxy-3-hydroxyleprotene

C41H50O2 (574.3811)

tri-(2-tert-butyl-4-methylphenyl)phosphite

C33H51O6P (574.3423)

Fmoc-Lys(ivDde)-OH

C34H42N2O6 (574.3043)

Phorbol 13-myristate

C34H54O7 (574.3869)

1,1-(decane-1,10-diyl)bis[4-amino-2-methylquinolinium] diacetate

C34H46N4O4 (574.3519)

zinc palmitate

C32H62O4Zn (574.3939)

(2R)-2-[[(1R,3S,4S)-3-[[4-(5-Benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-(3-fluorophenyl)cyclopentyl]-methylamino]-3-methylbutanoic acid

C35H47FN4O2 (574.3683)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D065100 - CCR5 Receptor Antagonists

solasodine 3-O-beta-D-glucopyranoside

C33H52NO7 (574.3744)

Solasodine 3-o-beta-d-glucopyranoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Solasodine 3-o-beta-d-glucopyranoside can be found in a number of food items such as black crowberry, canada blueberry, fig, and cherry tomato, which makes solasodine 3-o-beta-d-glucopyranoside a potential biomarker for the consumption of these food products. Solasodine 3-o-β-d-glucopyranoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Solasodine 3-o-β-d-glucopyranoside can be found in a number of food items such as black crowberry, canada blueberry, fig, and cherry tomato, which makes solasodine 3-o-β-d-glucopyranoside a potential biomarker for the consumption of these food products.

(2R)-2-[[(1R,3S,4S)-3-[[4-(5-Benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-(3-fluorophenyl)cyclopentyl]-methylamino]-3-methylbutanoic acid

C35H47FN4O2 (574.3683)

18-Hydroxy-chi,chi-caroten-18-oic acid

C40H46O3 (574.3447)

[(E,6R)-6-[(2S,9R,10R,13R,14S,16R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H46O9 (574.3142)

[(2S,3R,4R,5S)-2-[(1S,2R,4R,5S,7S,11S,12S,15R,16S)-4,5-dihydroxy-2,16-dimethyl-8-oxo-9-oxatetracyclo[9.7.0.02,7.012,16]octadecan-15-yl]-5-ethyl-4-hydroxy-6-methylheptan-3-yl] hydrogen sulfate

C29H50O9S (574.3175)

PA(8:0/18:2(10E,12Z)+=O(9))

C29H51O9P (574.3271)

PA(18:2(10E,12Z)+=O(9)/8:0)

C29H51O9P (574.3271)

PA(8:0/18:2(9Z,11E)+=O(13))

C29H51O9P (574.3271)

PA(18:2(9Z,11E)+=O(13)/8:0)

C29H51O9P (574.3271)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H51O9P (574.3271)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H51O9P (574.3271)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H51O9P (574.3271)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H51O9P (574.3271)

(1R,4R,4aR,6Z,7aR,8aR,10S,11S,11aR,12aR,13aR)-1,13a-dihydroxy-11-isopropyl-4,7,8a-trimethyl-13-methylene-2-oxo-1,2,4,4a,5,7a,8,8a,9,10,11,11a,12,12a,13,13a-hexadecahydroindeno[5,6:4,5]cycloocta[1,2-c]pyran-10-yl 3-hydroxy-3,5-dimethylheptanoate

C34H54O7 (574.3869)

7,8-Dehydrocerberin

C32H46O9 (574.3142)

A cardenolide glycoside that is the 7,8-dehydroderivative of cerberin. Isolated from Cerbera manghas, it exhibits cytotoxic activity.

(6R)-6-[(3S,10S,13R,14R,15R,17R)-12-acetyloxy-3,15-dihydroxy-4,4,10,13,14-pentamethyl-7,11-dioxo-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

CID 154573514

C30H57NO7P+ (574.3872)

N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide

C34H46N4O4 (574.3519)

2,3-dihydroxypropyl [2-hydroxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propyl] hydrogen phosphate

C30H55O8P (574.3634)

PE-Cer 15:2;2O/12:1;O

C29H55N2O7P (574.3747)

PE-Cer 13:2;2O/14:1;O

C29H55N2O7P (574.3747)

PE-Cer 14:3;2O/13:0;O

C29H55N2O7P (574.3747)

PE-Cer 14:2;2O/13:1;O

C29H55N2O7P (574.3747)

PE-Cer 12:2;2O/15:1;O

C29H55N2O7P (574.3747)

PE-Cer 15:3;2O/12:0;O

C29H55N2O7P (574.3747)

Isodiotigenin triacetate

C33H50O8 (574.3506)

PMeOH 26:2

C30H55O8P (574.3634)

Cyclosieversigenin Derivative: 3,6-Di-Ac

C34H54O7 (574.3869)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate

C30H54O10 (574.3717)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C30H54O10 (574.3717)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C30H54O10 (574.3717)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-octadec-9-enoate

C30H54O10 (574.3717)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C30H54O10 (574.3717)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C30H54O10 (574.3717)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C30H54O10 (574.3717)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C30H55O8P (574.3634)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C30H55O8P (574.3634)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O8P (574.3634)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C30H55O8P (574.3634)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C30H55O8P (574.3634)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C30H55O8P (574.3634)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O8P (574.3634)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C30H55O8P (574.3634)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O8P (574.3634)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C30H55O8P (574.3634)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (4E,7E)-hexadeca-4,7-dienoate

C30H55O8P (574.3634)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C30H55O8P (574.3634)

2-[[2-butanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H57NO7P+ (574.3872)

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H53NO8P+ (574.3509)

2-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C29H53NO8P+ (574.3509)

2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H57NO7P+ (574.3872)

2-[[2-acetyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H57NO7P+ (574.3872)

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H57NO7P+ (574.3872)

YW3548

C34H54O7 (574.3869)

A terpene lactone that is obtained from Codinea simplex and acts as an inhibitor of glycerophosphoinositol biosynthesis.

MGDG O-21:2;O

C30H54O10 (574.3717)

DGGA 20:1

C29H50O11 (574.3353)

MGGA 21:1

C30H54O10 (574.3717)

PA O-14:1/14:1

C31H59O7P (574.3998)

PA O-16:2/12:0

C31H59O7P (574.3998)

PA O-18:2/10:0

C31H59O7P (574.3998)

PA O-20:0/7:3;O

C30H55O8P (574.3634)

PA O-26:4;O2

C29H51O9P (574.3271)

PA O-27:3;O

C30H55O8P (574.3634)

PA O-28:2

C31H59O7P (574.3998)

PA P-14:0/14:1

C31H59O7P (574.3998)

PA P-14:0/14:1 or PA O-14:1/14:1

C31H59O7P (574.3998)

PA P-16:0/11:2;O

C30H55O8P (574.3634)

PA P-16:1/12:0

C31H59O7P (574.3998)

PA P-16:1/12:0 or PA O-16:2/12:0

C31H59O7P (574.3998)

PA P-18:0/8:3;O2

C29H51O9P (574.3271)

PA P-18:1/10:0

C31H59O7P (574.3998)

PA P-18:1/10:0 or PA O-18:2/10:0

C31H59O7P (574.3998)

PA P-18:1/8:2;O2

C29H51O9P (574.3271)

PA P-18:1/9:1;O

C30H55O8P (574.3634)

PA P-28:1

C31H59O7P (574.3998)

PA P-28:1 or PA O-28:2

C31H59O7P (574.3998)

PA 14:0/12:3;O

C29H51O9P (574.3271)

PA 18:0/8:3;O

C29H51O9P (574.3271)

PA 18:2/8:1;O

C29H51O9P (574.3271)

PA 20:1/6:2;O

C29H51O9P (574.3271)

PA 22:2/4:1;O

C29H51O9P (574.3271)

PA 26:3;O

C29H51O9P (574.3271)

PA 10:0_17:2

C30H55O8P (574.3634)

PA 27:2

C30H55O8P (574.3634)

LPEth 26:2

C31H59O7P (574.3998)

LPM 27:2

C31H59O7P (574.3998)

PEth 24:3;O

C29H51O9P (574.3271)

PEth 25:2

C30H55O8P (574.3634)

PM 25:3;O

C29H51O9P (574.3271)

PM 26:2

C30H55O8P (574.3634)

CerPE 12:2;O2/15:1;O

C29H55N2O7P (574.3747)

ST 26:4;O3;GlcA

C32H46O9 (574.3142)

ST 27:3;O2;GlcA

C33H50O8 (574.3506)

ST 28:2;O;GlcA

C34H54O7 (574.3869)

ST 23:0;O6;Hex

C29H50O11 (574.3353)

ST 26:5;O4;Hex

C32H46O9 (574.3142)

ST 27:4;O3;Hex

C33H50O8 (574.3506)

ST 28:3;O2;Hex

C34H54O7 (574.3869)

ST 29:1;O6;S

C29H50O9S (574.3175)

1-[3-(2-{5-hydroxy-1,6,6-trimethyl-4-oxo-3,7-dioxaspiro[bicyclo[3.2.1]octane-2,2'-oxan]-5'-yl}ethyl)-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

7-(acetyloxy)-1-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C34H54O7 (574.3869)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15bs)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,5r,5's)-5-hydroxy-1,6,6-trimethyl-4-oxo-3,7-dioxaspiro[bicyclo[3.2.1]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

[(1s,9s,10r,11r,17s)-12-{[(4r,12r,13s,16s,17r,18s,20r,21e)-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-21-ylidene]methyl}-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,12-tetraen-10-yl]methanol

C37H42N4O2 (574.3308)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15br)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1s)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

10-(acetyloxy)-4,7,11-trihydroxy-9a,11a-dimethyl-1-{1-[2-methyl-2-(3-methylbutan-2-yl)cyclopropyl]ethyl}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

C34H54O7 (574.3869)

[10-(acetyloxy)-1,6,9-trihydroxy-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-3a-yl]methyl acetate

C34H54O7 (574.3869)

(6r)-6-[(3r,3ar,7s)-3,7-dihydroxy-3a,6,6,9a,11,11a-hexamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-(acetyloxy)-2-methyl-4-oxohexanoic acid

C32H46O9 (574.3142)

5-(4,6-dimethyl-7-oxonon-5-en-2-yl)-1,7,11-trihydroxy-6,8,16,18-tetramethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-3-one

C34H54O7 (574.3869)

6-[(3as,4r,7r,9ar,11r,11as)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

14-(4-hydroxy-5,6-dimethyl-3-oxoheptan-2-yl)-2,15-dimethyl-9-oxo-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-7-en-5-yl 2,3-dihydroxy-3-methylbutanoate

C33H50O8 (574.3506)

(3r)-3-[(2r,3r,6s)-4-hydroxy-2,3-dimethyl-6-[(2r)-5-methyl-2-(2-methylprop-1-en-1-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C36H46O6 (574.3294)

2-[2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

methyl (5ar,6r,7s,7as,7br,9as,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

2-[2-(acetyloxy)-3-[7-(acetyloxy)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]butyl]-3-hydroxy-3-methylbutyl acetate

C34H54O7 (574.3869)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

2'-o-acetyl cerleaside a

C32H46O9 (574.3142)

{"Ingredient_id": "HBIN006174","Ingredient_name": "2'-o-acetyl cerleaside a","Alias": "NA","Ingredient_formula": "C32H46O9","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC45C3CCC(C4=O)(C(CC5)C6=CC(=O)OC6)C)C)OC(=O)C)OC)O","Ingredient_weight": "574.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "349","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101338813","DrugBank_id": "NA"}

3β-o-(2'-o-acetyl-α-l-thevetosyl)-14β-hy-droxy-7-en-5β-card-20(22)-enolide

C32H46O9 (574.3142)

{"Ingredient_id": "HBIN008278","Ingredient_name": "3\u03b2-o-(2'-o-acetyl-\u03b1-l-thevetosyl)-14\u03b2-hy-droxy-7-en-5\u03b2-card-20(22)-enolide","Alias": "NA","Ingredient_formula": "C32H46O9","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4=CCC3C2)O)C6=CC(=O)OC6)C)C)OC(=O)C)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2s)-1-[(2s)-2-[(2s,3r)-2-{[(2r,3r)-3-amino-10-chloro-1,2-dihydroxydecylidene]amino}-n,3-dimethylpentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C28H51ClN4O6 (574.3497)

(2s)-1-[(2s)-2-[(2s,3s)-2-{[(2r,3r)-3-amino-10-chloro-1,2-dihydroxydecylidene]amino}-n,3-dimethylpentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C28H51ClN4O6 (574.3497)

[(1r,3s,3ar,5as,5bs,6s,7ar,9r,10r,11as,13ar,13bs)-10-(acetyloxy)-1,6,9-trihydroxy-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-3a-yl]methyl acetate

C34H54O7 (574.3869)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13br,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

9-(1-hydroxyethyl)-3-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-13-ene-7,11-dione

C32H46O9 (574.3142)

8-(acetyloxy)-3-hydroxy-4',5,5',5',19-pentamethyl-21-oxo-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H46O9 (574.3142)

2-{[3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-1h,2h,3h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1r,3s,3as,3bs,4s,7s,9ar,9bs,10s,11s,11ar)-10-(acetyloxy)-4,7,11-trihydroxy-9a,11a-dimethyl-1-[(1r)-1-[(1r,2r)-2-methyl-2-[(2r)-3-methylbutan-2-yl]cyclopropyl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

C34H54O7 (574.3869)

methyl 3-{5-hydroxy-2,3-dimethyl-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-8-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-6-yl}-3-phenylpropanoate

C36H46O6 (574.3294)

(2r,3s,4r,5s,6s)-2-{[(1r,4r,6s,9s,10r,13r,14r)-9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1s,2s,4r,5r,6r,11r,12r,16r,18s,21r)-2,9,11-trihydroxy-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-9,13-dien-8-one

C32H46O9 (574.3142)

methyl 7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(6r)-6-[(1r,3r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

methyl (5ar,6r,7s,7as,7br,9as,13as,13br,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

6-ethyl-8',9'-dihydroxy-10'-(hydroxymethyl)-7'-methoxy-5,6',14',16'-tetramethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-5',10',12',16'-tetraen-3'-one

C33H50O8 (574.3506)

[(2r)-5-oxo-1,4-dioxacyclopentacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H54O7 (574.3869)

2,9,11-trihydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-9,13-dien-8-one

C32H46O9 (574.3142)

2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9bs,11ar)-2,4-bis(acetyloxy)-5,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

6-[11a-(hydroxymethyl)-3a,6,6,9b-tetramethyl-7-oxo-1h,2h,3h,3bh,4h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-hydroxy-2-methylheptan-3-yl acetate

C34H54O7 (574.3869)

(3e,5e,7r,8s,9s,11e,13e,15s,16r)-16-[(2s,3r,4s,6e,8r,9r)-3,9-dihydroxy-4,8-dimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C34H54O7 (574.3869)

(2s,4ar,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-10-(acetyloxy)-11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C33H50O8 (574.3506)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,4r,5's)-4-hydroxy-1,5,5-trimethyl-8-oxo-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

(1''r,2''r,8''r,9's,9'as,10''s,11''r,12''s,16''s)-2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-3''-en-10''-yl acetate

C34H42N2O6 (574.3043)

methyl (5ar,6r,7s,7as,7br,9as,13as,13br,15as,15bs)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(6r)-6-[(1r,3ar,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(2r,3s,4r,5s,6s)-2-{[(1s,4r,6s,9s,10r,13r,14r)-9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(2r,3s,4r,5s,6s)-2-{[(1s,4r,6s,9s,10r,14r)-9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-13-(acetyloxy)-4-hydroxy-3,6,6,10,14-pentamethyl-9-[(2-methylbutanoyl)oxy]-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C32H46O9 (574.3142)

methyl 7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1r,2s,5s,10r,11s,14r,15r,17r)-14-[(2s,4s,5r)-4-hydroxy-5,6-dimethyl-3-oxoheptan-2-yl]-2,15-dimethyl-9-oxo-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-7-en-5-yl 2,3-dihydroxy-3-methylbutanoate

C33H50O8 (574.3506)

(5-oxo-1,4-dioxacyclopentacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H54O7 (574.3869)

3-[(1s,2r,3br,4r,5ar,9as,9br,10r,11as)-2,4,10-trihydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

C32H46O9 (574.3142)

1-(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n,3-dimethylpentanamido}-4-methylpentanoyl)pyrrolidine-2-carboxylic acid

C28H51ClN4O6 (574.3497)

6-[11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

2'',7'',7'',11'',16''-pentamethyl-3',5''-dioxo-1',9'a-dihydrodispiro[cyclopropane-1,2'-imidazo[1,2-a]indole-9',14''-[6,15]dioxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan]-3''-en-10''-yl acetate

C34H42N2O6 (574.3043)

methyl (3s)-3-[(2r,3r,8r)-5-hydroxy-2,3-dimethyl-8-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-8-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-6-yl]-3-phenylpropanoate

C36H46O6 (574.3294)

6-[11-(acetyloxy)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

[(1r,3s,3ar,5as,5bs,6s,7ar,9r,10r,11as,13ar,13br)-10-(acetyloxy)-1,6,9-trihydroxy-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-3a-yl]methyl acetate

C34H54O7 (574.3869)

(2r)-2-[(2r,3s)-3-[(1r,3as,3bs,7s,9ar,9bs,11as)-7-(acetyloxy)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-(acetyloxy)butyl]-3-hydroxy-3-methylbutyl acetate

C34H54O7 (574.3869)

2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl 3-hydroxypentanoate

C34H54O7 (574.3869)

(1s,3r,4s,5s,9r)-9-[(1r)-1-hydroxyethyl]-3-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-13-ene-7,11-dione

C32H46O9 (574.3142)

butyl 4-[11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate

C33H50O8 (574.3506)

(1s,2s,3s,4as,4br,6as,7s,10as,10br,12s,12as)-2-acetyl-12-(acetyloxy)-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-tetradecahydrochrysen-3-yl (3s)-3-hydroxypentanoate

C34H54O7 (574.3869)

(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14bs)-10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl acetate

C34H54O7 (574.3869)

11-(acetyloxy)-4,7,10-trihydroxy-9a,11a-dimethyl-1-{1-[2-methyl-2-(3-methylbutan-2-yl)cyclopropyl]ethyl}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

C34H54O7 (574.3869)

2-[(1z,2s,3as,3bs,4r,5r,5as,6s,7r,9ar,9br,11ar)-2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

butyl (4r)-4-[(1r,3ar,4s,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate

C33H50O8 (574.3506)

(2r,3r,4s,5s,6r)-2-[(2r,3r)-3-[(1r,3r,4r,9s,10r,13s,14s,15s)-3,14-dihydroxy-15-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]-2,3-dihydroxypropoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C29H50O11 (574.3353)

2-{[9,13-dimethyl-17-oxo-14-(5-oxo-2h-furan-3-yl)tetracyclo[11.3.1.0¹,¹⁰.0⁴,⁹]heptadecan-6-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

3-{4-hydroxy-2,3-dimethyl-6-[5-methyl-2-(2-methylprop-1-en-1-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl}-3-phenylpropanoic acid

C36H46O6 (574.3294)

(3r,5r,6s)-6-[(3as,3br,9as,9br,11as)-11a-(hydroxymethyl)-3a,6,6,9b-tetramethyl-7-oxo-1h,2h,3h,3bh,4h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-hydroxy-2-methylheptan-3-yl acetate

C34H54O7 (574.3869)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13bs,15as,15bs)-7-(acetyloxy)-6,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1r,3s,3as,3br,4s,7s,9ar,9bs,10s,11s,11ar)-11-(acetyloxy)-4,7,10-trihydroxy-9a,11a-dimethyl-1-[(1r)-1-[(1r,2r)-2-methyl-2-[(2r)-3-methylbutan-2-yl]cyclopropyl]ethyl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

C34H54O7 (574.3869)

2-{3-[3,14-dihydroxy-15-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]-2,3-dihydroxypropoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C29H50O11 (574.3353)

methyl 6-(acetyloxy)-7,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,12,15a-tetramethyl-3-oxo-5h,6h,7h,7ah,8h,9h,10h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1s,2s,3s,5s,7s,9r,11s,12s,13s,15r,16r,18r)-13-(acetyloxy)-3,5-dihydroxy-2,16-dimethyl-15-[(1r)-1-[(1r,2r)-2-methyl-2-[(2r)-3-methylbutan-2-yl]cyclopropyl]ethyl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-18-yl acetate

C34H54O7 (574.3869)

3-[(5-aminopentyl)(hydroxy)carbamoyl]-n-[5-(n-hydroxy-3-{[5-(n-hydroxypropanamido)pentyl]-c-hydroxycarbonimidoyl}propanamido)pentyl]propanimidic acid

C26H50N6O8 (574.369)

2-{[3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(2r,3r,4r,5s,6s)-2-{[(3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-5-hydroxy-4-methoxy-6-methyloxan-3-yl acetate

C32H46O9 (574.3142)

(1r,3s,4s,4's,5s,7r,8s,10s,13s,14s,16s,18s,19r,22r)-8-(acetyloxy)-3-hydroxy-4',5,5',5',19-pentamethyl-21-oxo-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-7-yl acetate

C32H46O9 (574.3142)

(3r)-3-[(2s,3r,6s)-4-hydroxy-2,3-dimethyl-6-[(2r)-5-methyl-2-(2-methylprop-1-en-1-yl)hex-5-en-1-yl]-6-(3-methylbut-2-en-1-yl)-5,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]-3-phenylpropanoic acid

C36H46O6 (574.3294)

13-(acetyloxy)-3,5-dihydroxy-2,16-dimethyl-15-{1-[2-methyl-2-(3-methylbutan-2-yl)cyclopropyl]ethyl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-18-yl acetate

C34H54O7 (574.3869)

4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-(4-methoxy-2,3,6-trimethylphenyl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,3,5-trimethylphenol

C41H50O2 (574.3811)

(1's,2s,4'r,5r,6s,8's,10'e,12's,13'r,14'e,16'e,20'r,21's,24'r)-6-ethyl-12',21',24'-trihydroxy-11'-(hydroxymethyl)-5,13',22'-trimethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-one

C32H46O9 (574.3142)

(2s,3e,5r)-10-[(1s,3s,6s)-6-(acetyloxy)-3-hydroxy-2,2,6-trimethylcyclohexyl]-5-hydroxy-3,8-dimethyl-1-[(1r)-2,6,6-trimethyl-5-oxocyclohex-2-en-1-yl]deca-3,7-dien-2-yl acetate

C34H54O7 (574.3869)

(3e,6r)-6-[(1r,2r,3as,3bs,4s,8s,9ar,9bs,11ar)-2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H46O9 (574.3142)

6-hydroxy-2-methyl-5-oxo-6-{2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-yl acetate

C32H46O9 (574.3142)

6-hydroxy-7,7-dimethyl-5-oxo-3-{2,4,10-trihydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}oxepan-2-yl acetate

C32H46O9 (574.3142)

(3r,5r,6s)-6-[(1r,3as,3br,9as,9br,11as)-11a-(hydroxymethyl)-3a,6,6,9b-tetramethyl-7-oxo-1h,2h,3h,3bh,4h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-hydroxy-2-methylheptan-3-yl acetate

C34H54O7 (574.3869)

(2r,6r)-6-[(1s,3ar,4s,5ar,7s,9as,11s,11as)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

[(1r,3s,3ar,5as,5bs,6s,7as,9r,10r,11as,13ar,13br)-10-(acetyloxy)-1,6,9-trihydroxy-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-3a-yl]methyl acetate

C34H54O7 (574.3869)

(2r,6r)-6-[(1r,2s,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-2,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(1s)-1-[(1s,3r)-3-{2-[(1s,2s,4r,5'r)-4-hydroxy-1,5,5-trimethyl-8-oxo-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl]ethyl}-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

(1s,3as,3br,7s,9ar,9bs,11r,11as)-1-acetyl-3a-hydroxy-7-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-2-methylbut-2-enoate

C33H50O8 (574.3506)

(1s,3br,4r,5ar,7r,9as,9br,11as)-7-(acetyloxy)-1-[(3r,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C34H54O7 (574.3869)

methyl 6-(acetyloxy)-7,13a-dihydroxy-5a-(1-hydroxyethyl)-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

2-[2,4-bis(acetyloxy)-5,7-dihydroxy-3a,3b,6,9a-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H50O8 (574.3506)

10-(acetyloxy)-11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C33H50O8 (574.3506)

(1r,5r,6r,7s,8r,9z,11s,15e,17r)-5-[(2s,4s,5e)-4,6-dimethyl-7-oxonon-5-en-2-yl]-1,7,11-trihydroxy-6,8,16,18-tetramethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-3-one

C34H54O7 (574.3869)

methyl (5ar,6r,7s,7as,7br,9ar,13as,13bs,15as,15bs)-6-(acetyloxy)-7,13a-dihydroxy-5a-[(1r)-1-hydroxyethyl]-7b,9a,15a-trimethyl-12-methylidene-3-oxo-5h,6h,7h,7ah,8h,9h,10h,11h,13h,14h,15h,15bh-chryseno[2,1-c]oxepine-13b-carboxylate

C32H46O9 (574.3142)

(1r,3br,4r,5ar,7r,9as,9br,11as)-7-(acetyloxy)-1-[(3s,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C34H54O7 (574.3869)

1-(2-{[2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-n-(5-carbamimidamido-1-oxopentan-2-yl)pyrrolidine-2-carboximidic acid

C28H42N6O7 (574.3115)

(2r,6s)-6-[(1s,3ar,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

(1r,3s,4r,5r,9s)-9-[(1s)-1-hydroxyethyl]-3-[(2r,5r)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadec-13-ene-7,11-dione

C32H46O9 (574.3142)

(2r,6r)-6-[(1r,3ar,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H46O9 (574.3142)

6-[2,8-dihydroxy-9b-(hydroxymethyl)-3a,6,6,11a-tetramethyl-7,10-dioxo-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H46O9 (574.3142)

(1s,4r,4as,6as,6br,8as,10s,12ar,12br,14bs)-1,6a,6b,9,9,12a-hexamethyl-10-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,2,3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4-carboxylic acid

C34H54O7 (574.3869)

1-[3-(2-{4-hydroxy-1,5,5-trimethyl-8-oxo-3,6-dioxaspiro[bicyclo[2.2.2]octane-2,2'-oxan]-5'-yl}ethyl)-2,2-dimethyl-6-methylidenecyclohexyl]-2-(2-oxooxolan-3-ylidene)ethyl acetate

C32H46O9 (574.3142)

(1's,2r,4'r,5s,6r,7'r,8'r,9's,10'e,12'e,14'r,16'e,19'r)-6-ethyl-8',9'-dihydroxy-10'-(hydroxymethyl)-7'-methoxy-5,6',14',16'-tetramethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-5',10',12',16'-tetraen-3'-one

C33H50O8 (574.3506)

1,6a,6b,9,9,12a-hexamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,2,3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4-carboxylic acid

C34H54O7 (574.3869)

(2r,3s,6s)-3-[(1s,2r,3br,4r,5ar,9as,9br,10r,11as)-2,4,10-trihydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

C32H46O9 (574.3142)

10-(acetyloxy)-3-hydroxy-2-(hydroxymethyl)-2-methoxy-4a,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl acetate

C34H54O7 (574.3869)